Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2001
11/21/2001CN1075064C New benzoxazinedione derivatives, and producing process thereof and use
11/21/2001CN1074922C Oral liquid composition containing paroxetine resinate
11/21/2001CN1074917C Stable carotenoid emulsions adapted for parenteral administration
11/20/2001US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001US6320050 2-substituted phenyl-3-cycloalkyl substituted n-heteroaromatic propionamides; used to increase insulin secretion in the treatment of type ii diabetes.
11/20/2001US6320022 Adrenomedullin peptides
11/20/2001US6319938 Prophylactic or therapeutic drug for renal diseases
11/20/2001US6319935 Used in treatment of elevated intraocular pressure, non insulin-dependent diabetes, male impotence and obesity
11/20/2001US6319930 Substituted dimeric compounds
11/20/2001US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001US6319698 Method for producing arachidonic acid
11/20/2001US6319520 Copolymers of ammonium methacrylate that consist of fully polymerized copolymers of acrylic acid and methacrylic acid ester having quaternary ammonium groups
11/20/2001CA2024843C Synthesis of mannojirimycin derivatives
11/20/2001CA1341320C Insulinotropic hormone
11/15/2001WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001WO2001085711A1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters
11/15/2001WO2001085707A1 Para-amine substituted phenylamide glucokinase activators
11/15/2001WO2001085706A1 Substituted phenylacetamides and their use as glucokinase activators
11/15/2001WO2001085702A1 (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-(3r,5s)-dihydroxyhept-6-enoic acid.
11/15/2001WO2001085698A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001WO2001085694A2 Substituted diamide derivatives useful as motilin antagonists
11/15/2001WO2001085693A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001WO2001085690A1 4-alkyl and 4-cycloalkyl derivatives of dihydropyridine npy antagonists
11/15/2001WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001WO2001085256A2 Critical illness neuropathy
11/15/2001WO2001085201A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
11/15/2001WO2001085193A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/15/2001WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001WO2001085149A2 Felbamate derived compounds
11/15/2001WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
11/15/2001WO2001085098A2 Squarate derivatives of dihydropyridine npy antagonists
11/15/2001WO2001084963A1 Edible composition containing micronised nacre powder
11/15/2001WO2001055172A3 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN
11/15/2001WO2001047498A3 Hydrogel-driven layered drug dosage form comprising sertraline
11/15/2001WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001WO2001017963A3 Aminoalkoxy carbazoles and their use as 5-ht ligands
11/15/2001WO2001016136B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
11/15/2001WO2001000187A3 Pharmaceutical composition containing sibutramine and a lipase inhibitor
11/15/2001WO2000078950A3 Differentially expressed genes in the adipocytes of obese mice
11/15/2001WO2000057865A9 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
11/15/2001WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001US20010041809 Novel forms of pravastatin sodium
11/15/2001US20010041802 Glucocorticoid receptor antagonists for treatment of diabetes
11/15/2001US20010041738 Containing trace elements
11/15/2001US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001US20010041705 Heterocyclic carboxamides
11/15/2001US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts
11/15/2001US20010041669 Administering to mammal an effective amount of a hormonally inactive insulin or insulin analogue
11/15/2001DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001DE10022518A1 Preparation of L-ascorbic acids by reacting 2-keto-L-gulonic acids or melt of 2-keto-L-gulonic acid alkyl esters under acid catalysis using water-miscible solvent(s)
11/15/2001DE10021731A1 Cyclipostine, Verfahren zu ihrer Herstellung und Verwendung derselben Cyclipostins, processes for their preparation and use thereof
11/15/2001CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof
11/15/2001CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
11/15/2001CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
11/15/2001CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001CA2408343A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001CA2408290A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001CA2408288A1 Novel substituted diamine derivatives useful as motilin antagonists
11/15/2001CA2408228A1 Method for promoting neovascularization
11/15/2001CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001CA2407850A1 Cytoskeleton-associated proteins
11/15/2001CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001CA2407697A1 Felbamate derived compounds
11/15/2001CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001CA2404987A1 (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-(3r,5s)-dihydroxyhept-6-enoic acid.
11/14/2001EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001EP1153609A1 Amino acid-containing albumin preparations
11/14/2001EP1153603A2 New treatments using phenethylamine derivatives
11/14/2001EP1153131A2 Peroral gene therapy of diabetes and obesity
11/14/2001EP1153123A2 Pluripotential cells-2
11/14/2001EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001EP1153035A2 Human lipid-associated proteins
11/14/2001EP1153013A2 5-ht1f agonists
11/14/2001EP1152760A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
11/14/2001EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
1 ... 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 ... 1298